Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat

Clinical trial NCT04712942 · COMPLETED

Trial details

NCT number: NCT04712942
Sponsor: University of Leipzig
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia in Remission Myelodysplastic Syndromes Minimal Residual Disease

Start date: 2021-01-01
Primary completion: 2023-01-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.